BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36980538)

  • 1. Survival in People Living with HIV with or without Recurrence of Hepatocellular Carcinoma after Invasive Therapy.
    Bertoni C; Galli L; Lolatto R; Hasson H; Siribelli A; Messina E; Castagna A; Uberti Foppa C; Morsica G
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transplant infection improves outcome of hepatocellular carcinoma patients after orthotopic liver transplantation.
    Chao JS; Zhao SL; Ou-Yang SW; Qian YB; Liu AQ; Tang HM; Zhong L; Peng ZH; Xu JM; Sun HC
    World J Gastroenterol; 2019 Oct; 25(37):5630-5640. PubMed ID: 31602163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recipient C7 rs9292795 genotype and the risk of hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
    Jiang Z; Jiang Q; Fang X; Wang P; Que W; Li H; Yu Y; Liu X; Wang C; Zhong L
    BMC Cancer; 2021 May; 21(1):521. PubMed ID: 33964921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver Imaging-Reporting and Data System treatment response algorithm predicts postsurgical recurrence in locoregional therapy-treated hepatocellular carcinoma.
    Youn SY; Kim B; Kim DH; Choi HJ; Sung PS; Choi JI
    Eur Radiol; 2022 Sep; 32(9):6270-6280. PubMed ID: 35348864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between donor and recipient smoothened gene polymorphisms and the risk of hepatocellular carcinoma recurrence following orthotopic liver transplantation in a Han Chinese population.
    Wang P; Song W; Li H; Wang C; Shi B; Guo W; Zhong L
    Tumour Biol; 2015 Sep; 36(10):7807-15. PubMed ID: 25944162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter Study of Staging and Therapeutic Predictors of Hepatocellular Carcinoma Recurrence Following Transplantation.
    Welling TH; Eddinger K; Carrier K; Zhu D; Kleaveland T; Moore DE; Schaubel DE; Abt PL
    Liver Transpl; 2018 Sep; 24(9):1233-1242. PubMed ID: 29729113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Combination of AFP and "Up-To-Seven" Criteria May Be a Better Strategy for Liver Transplantation in Chinese Cirrhotic HCC Patients.
    Zhang DL; Feng DN; He X; Zhang XF; Li LX; Li ZJ; Niu XF; Zhuang YL; Liu ZW; Gao XD; Wang HB
    Front Oncol; 2022; 12():959151. PubMed ID: 35936699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of Alpha-Fetoprotein and Association with Mortality in Hepatocellular Carcinoma of HIV-1-Infected Patients.
    Morsica G; Galli L; Messina E; Cibarelli A; Bagaglio S; Poli A; Ranzenigo M; Castagna A; Hasson H; Uberti-Foppa C
    J Oncol; 2022; 2022():3586064. PubMed ID: 35186078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of traditional herbal medicine versus transcatheter arterial chemoembolization in postsurgical patients with hepatocellular carcinoma: A retrospective study.
    Xu X; Chen R; Chen Q; An K; Ding L; Zhang L; Wang F; Deng Y
    Complement Ther Clin Pract; 2021 May; 43():101359. PubMed ID: 33711747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LI-RADS category 5 hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MRI for early recurrence risk stratification after curative resection.
    Wei H; Jiang H; Zheng T; Zhang Z; Yang C; Ye Z; Duan T; Song B
    Eur Radiol; 2021 Apr; 31(4):2289-2302. PubMed ID: 33001306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
    Saab S; Yeganeh M; Nguyen K; Durazo F; Han S; Yersiz H; Farmer DG; Goldstein LI; Tong MJ; Busuttil RW
    Liver Transpl; 2009 Nov; 15(11):1525-34. PubMed ID: 19877207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma.
    Xing M; Sakaria S; Dhanasekaran R; Parekh S; Spivey J; Knechtle SJ; Zhang D; Kim HS
    Cardiovasc Intervent Radiol; 2017 Mar; 40(3):410-420. PubMed ID: 27900445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study.
    Peng ZW; Lin XJ; Zhang YJ; Liang HH; Guo RP; Shi M; Chen MS
    Radiology; 2012 Mar; 262(3):1022-33. PubMed ID: 22357902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation.
    Han ZB; Chen HY; Fan JW; Wu JY; Tang HM; Peng ZH
    J Cancer Res Clin Oncol; 2012 Jan; 138(1):153-61. PubMed ID: 22071603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Bridging Locoregional Therapy and Sociodemographics on Survival in Hepatocellular Carcinoma Patients Undergoing Orthotopic Liver Transplantation: A United Network for Organ Sharing Population Study.
    Magnetta MJ; Xing M; Zhang D; Kim HS
    J Vasc Interv Radiol; 2016 Dec; 27(12):1822-1828. PubMed ID: 27692856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of protein phosphatase 2 regulatory subunit B'' alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation.
    He JJ; Shang L; Yu QW; Jiao N; Qiu S; Zhu WX; Wu DF; Tian YE; Zhang Q
    World J Gastrointest Oncol; 2021 Jul; 13(7):716-731. PubMed ID: 34322200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
    Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
    Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization.
    Gabr A; Abouchaleh N; Ali R; Vouche M; Atassi R; Memon K; Asadi AA; Baker T; Caicedo JC; Desai K; Fryer J; Hickey R; Abeccassis M; Habib A; Hohlastos E; Ganger D; Kulik L; Lewandowski RJ; Riaz A; Salem R
    Eur J Radiol; 2017 Aug; 93():100-106. PubMed ID: 28668402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.
    Han ZB; Zhong L; Teng MJ; Fan JW; Tang HM; Wu JY; Chen HY; Wang ZW; Qiu GQ; Peng ZH
    Mol Oncol; 2012 Aug; 6(4):445-57. PubMed ID: 22552153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.